EIF4B and cancer: In total, the identification of hypoxia-dependent RNA–protein complexes such as eif4b and map2k1 and their molecular characterization in cancer signaling should provide insight into new pathways that may modulate translation rates in resistant and hypoxic cancer cells [54].